Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries

The safety of parenteral nutrition (PN) remains a concern in preterm neonates, impacting clinical outcomes and health-care-resource use and costs. This cost-consequence analysis assessed national-level impacts of a 10-percentage point increase in use of industry-prepared three-chamber bags (3CBs) on...

Full description

Bibliographic Details
Main Authors: Alexander Kriz, Antony Wright, Mattias Paulsson, Stephen Tomlin, Venetia Simchowitz, Thibault Senterre, Julian Shepelev
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/12/9/2531
id doaj-00ea29ec477e4a30934c9213ea060108
record_format Article
spelling doaj-00ea29ec477e4a30934c9213ea0601082020-11-25T03:52:41ZengMDPI AGNutrients2072-66432020-08-01122531253110.3390/nu12092531Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European CountriesAlexander Kriz0Antony Wright1Mattias Paulsson2Stephen Tomlin3Venetia Simchowitz4Thibault Senterre5Julian Shepelev6Executive Insight AG, 8008 Zurich, SwitzerlandMaverex Ltd., Newcastle upon Tyne NE6 2HL, UKDepartment of Women’s and Children’s Health, Uppsala University, 751 85 Uppsala, SwedenGreat Ormond Street Hospital, London WC1N 3JH, UKGreat Ormond Street Hospital, London WC1N 3JH, UKDepartment of Neonatology, Liège University, 4000 Liège, BelgiumBaxter Healthcare Ltd., Compton RG20 7QW, UKThe safety of parenteral nutrition (PN) remains a concern in preterm neonates, impacting clinical outcomes and health-care-resource use and costs. This cost-consequence analysis assessed national-level impacts of a 10-percentage point increase in use of industry-prepared three-chamber bags (3CBs) on clinical outcomes, healthcare resources, and hospital budgets across seven European countries. A ten-percentage-point 3CB use-increase model was developed for Belgium, France, Germany, Italy, Portugal, Spain, and the UK. The cost-consequence analysis estimated the impact on compounding error harm and bloodstream infection (BSI) rates, staff time, and annual hospital budget. Of 265,000 (52%) preterm neonates, 133,000 (52%) were estimated to require PN. Baseline compounding methods were estimated as 43% pharmacy manual, 16% pharmacy automated, 22% ward, 9% outsourced, 3% industry provided non-3CBs, and 7% 3CBs. A modeled increased 3CB use would change these values to 39%, 15%, 18%, 9%, 3%, and 17%, respectively. Modeled consequences included −11.6% for harm due to compounding errors and −2.7% for BSIs. Labor time saved would equate to 41 specialized nurses, 29 senior pharmacists, 26 pharmacy assistants, and 22 senior pediatricians working full time. Budget impact would be a €8,960,601 (3.4%) fall from €260,329,814 to €251,369,212. Even a small increase in the use of 3CBs in preterm neonates could substantially improve neonatal clinical outcomes, and provide notable resource and cost savings to hospitals.https://www.mdpi.com/2072-6643/12/9/2531preterm neonatescompounding errorsparenteral nutritionready-to-use three-chamber-bagscost-consequence analysis
collection DOAJ
language English
format Article
sources DOAJ
author Alexander Kriz
Antony Wright
Mattias Paulsson
Stephen Tomlin
Venetia Simchowitz
Thibault Senterre
Julian Shepelev
spellingShingle Alexander Kriz
Antony Wright
Mattias Paulsson
Stephen Tomlin
Venetia Simchowitz
Thibault Senterre
Julian Shepelev
Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries
Nutrients
preterm neonates
compounding errors
parenteral nutrition
ready-to-use three-chamber-bags
cost-consequence analysis
author_facet Alexander Kriz
Antony Wright
Mattias Paulsson
Stephen Tomlin
Venetia Simchowitz
Thibault Senterre
Julian Shepelev
author_sort Alexander Kriz
title Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries
title_short Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries
title_full Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries
title_fullStr Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries
title_full_unstemmed Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries
title_sort cost-consequences analysis of increased utilization of triple-chamber-bag parenteral nutrition in preterm neonates in seven european countries
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2020-08-01
description The safety of parenteral nutrition (PN) remains a concern in preterm neonates, impacting clinical outcomes and health-care-resource use and costs. This cost-consequence analysis assessed national-level impacts of a 10-percentage point increase in use of industry-prepared three-chamber bags (3CBs) on clinical outcomes, healthcare resources, and hospital budgets across seven European countries. A ten-percentage-point 3CB use-increase model was developed for Belgium, France, Germany, Italy, Portugal, Spain, and the UK. The cost-consequence analysis estimated the impact on compounding error harm and bloodstream infection (BSI) rates, staff time, and annual hospital budget. Of 265,000 (52%) preterm neonates, 133,000 (52%) were estimated to require PN. Baseline compounding methods were estimated as 43% pharmacy manual, 16% pharmacy automated, 22% ward, 9% outsourced, 3% industry provided non-3CBs, and 7% 3CBs. A modeled increased 3CB use would change these values to 39%, 15%, 18%, 9%, 3%, and 17%, respectively. Modeled consequences included −11.6% for harm due to compounding errors and −2.7% for BSIs. Labor time saved would equate to 41 specialized nurses, 29 senior pharmacists, 26 pharmacy assistants, and 22 senior pediatricians working full time. Budget impact would be a €8,960,601 (3.4%) fall from €260,329,814 to €251,369,212. Even a small increase in the use of 3CBs in preterm neonates could substantially improve neonatal clinical outcomes, and provide notable resource and cost savings to hospitals.
topic preterm neonates
compounding errors
parenteral nutrition
ready-to-use three-chamber-bags
cost-consequence analysis
url https://www.mdpi.com/2072-6643/12/9/2531
work_keys_str_mv AT alexanderkriz costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries
AT antonywright costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries
AT mattiaspaulsson costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries
AT stephentomlin costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries
AT venetiasimchowitz costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries
AT thibaultsenterre costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries
AT julianshepelev costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries
_version_ 1724481499201273856